Clariant's promise to create added value by appreciating the needs of its pharmaceutical sector customers will take center stage at the CPhI 2012. Presented for the first time under the company's new branding, the specialty chemicals expert's trusted high purity processing solutions can help meet the efficiency and performance requirements of specific pharmaceutical formulations. Clariant is a firm believer in working closely with customers in order to maximize the benefits of its portfolio of building blocks, enhancers, and ingredients for the processing of sensitive applications.

A highlight for CPhI 2012 visitors will be Clariant's portfolio of Pharmaceutical PEGs/ Macrogols, a product range under the trade name Polyglykol, used as API in laxatives and as excipients for tablets, suppository masses, organ preservation, protein purification and drug delivery systems. Clariant offers a complete range of different molecular weight, high purity PEGs supported by CEP certification and DMF.

"Appreciation is the key to delivering the innovative and competitive processing solutions required by the pharmaceutical sector. This philosophy of listening to our customers is at the heart of Clariant and we are excited to have the opportunity to present this to the pharmaceutical community within the fresh look and feel of our new company branding at the forthcoming CPhI," comments Boris Segalowitch, Business Line Head Personal Care EMEA, Clariant.